Mad Money Lightning Round OT: Cramer Is A Buyer Of EVR (ALXN, CEPH, GENZ, EVR, ONCY)

On CNBC's Mad Money Lightning Round OT, Jim Cramer said that Alexion Pharmaceuticals, Inc. ALXN reminds him on Cephalon, Inc. CEPH, and Genzyme Corporation GENZ. It is the company that is doing a lot of good, and it is what this market wants. Cramer would stick with this stock. Cramer is a buyer of Evercore Partners Inc. EVR. He likes this stock as a M&A play. Evercore Partners Inc. (EVR) added 0.09%, and closed at $34.70. Cramer is not familiar with Oncolytics Biotech, Inc. (USA) ONCY, and he has to do some research, before he makes his call on this stock. Oncolytics Biotech (ONCY) fell 0.85%, and it closed at $5.80.